Preferred Label : trimetrexate;
MeSH definition : A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate
reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic
agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting
toxic effect.;
CISMeF synonym : trimetrexate ipsen brand; ipsen brand of trimetrexate;
MeSH hyponym : JB-11; trimetrexate hydrate; trimetrexate monohydrate, monoacetate; NSC-328564; NSC-249008; CI-898; JB 11; JB11; Monohydrate, Monoacetate Trimetrexate; NSC 328564; NSC328564; Hydrate, Trimetrexate; CI 898; CI898; NSC 249008; NSC249008;
MeSH CAS label : 2,4-Quinazolinediamine, 5-methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-;
MeSH Related Number : trimetrexate monohydrate, monoacetate; trimetrexate hydrate; 117381-09-6 (monohydrate, monoacetate); 117381-10-9 (hydrate); 52128-35-5 (Trimetrexate);
Registry Number MeSH : 52128-35-5;
Related CAS MeSH : 117381-09-6 (Trimetrexate monohydrate, monoacetate); 117381-10-9 (Trimetrexate hydrate);
Is substance : O;
UNII : UPN4ITI8T4;
InChIKey : NOYPYLRCIDNJJB-UHFFFAOYSA-N;
Origin ID : D016597;
UMLS CUI : C0085176;
ATC code(s)
ATC code(s)
Allowable qualifiers
Currated CISMeF NLP mapping
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A nonclassical folic acid inhibitor through its inhibition of the enzyme dihydrofolate
reductase. It is being tested for efficacy as an antineoplastic agent and as an antiparasitic
agent against PNEUMOCYSTIS PNEUMONIA in AIDS patients. Myelosuppression is its dose-limiting
toxic effect.